Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021691	b-plas-p	— (—)	56	135	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

19.99

19.58

2.7

2.1

—

Intestinal infectious diseases

6.66

14.60

2.2

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

6.18

7.06

2.1

2.8

—

General symptoms and signs

5.01

6.94

2.5

2.3

—

Explicit Sepsis

7.28

5.44

2.8

2.7

—

Explicit Sepsis, including avohilmo

7.25

5.42

2.8

2.7

—

Persons with potential health hazards related to communicable diseases

7.00

5.39

2.3

2.6

—

Contact with and exposure to communicable diseases

6.85

4.92

2.2

2.6

—

L04AX Other immunosuppressants

5.41

4.90

2.2

2.6

—

Intestinal infectious diseases, including avohilmo, including avohilmo

3.58

4.78

1.9

2.6

—

Septicaemia

7.60

4.73

3.1

2.4

—

Second line medication for Crohn's disease

4.81

4.48

2.2

2.6

—

Other septicaemia

7.72

4.37

3.3

2.3

—

ILD medications: immunosuppressive drugs

4.37

4.36

2.5

2.7

—

Other septicaemia, including avohilmo

7.68

4.35

3.3

2.3

—

Bronchitis

3.08

4.01

2.1

2.6

—

COPD/asthma/ILD related infections

3.58

3.85

2.3

2.2

—

COPD/asthma related infections

3.58

3.85

2.3

2.2

—

Other bacterial diseases

3.43

3.76

2.8

2.2

—

IBD patients in KELA-register

7.78

3.55

2.3

2.9

—

Inflammatory bowel disease, strict (require KELA)

7.78

3.55

2.3

2.9

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3.20

3.39

1.6

2.6

—

Exposure to unspecified factor

2.72

3.05

2.2

2.5

—

Inflammatory bowel disease

5.83

3.02

2.3

2.8

—

Mucosal proctocolitis

10.01

2.98

2.4

3.2

—

2.92

2.95

2.3

2.5

—

Other/unspecified dorsalgia

4.65

2.88

2.5

3.0

—

ILD medications

2.62

2.85

2.2

2.5

—

Renal tubulo-interstitial diseases

2.88

2.80

2.9

2.2

—

ILD medications: azathioprine

8.34

2.75

2.6

2.8

—

Azathioprine

8.34

2.75

2.6

2.8

—

Ectopic pregnancy

8.34

2.75

2.2

2.7

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

8.33

2.75

2.2

2.8

—

Persons encountering health services in other circumstances

3.87

2.74

1.9

2.7

—

All influenza

6.00

2.69

2.0

2.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

7.14

2.55

2.4

2.7

—

Ulcerative colitis (strict definition, require KELA)

7.14

2.55

2.4

2.7

—

Acute upper respiratory infections of multiple and unspecified sites

2.82

2.51

2.1

2.5

—

Certain infectious and parasitic diseases

3.24

2.44

3.0

2.2

—

Malaise and fatigue

5.25

2.38

2.5

2.6

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

6.25

2.37

2.4

2.6

—

Peritonsillar abscess

6.25

2.37

1.8

2.4

—

5-aminosalicylic acid

6.25

2.37

2.4

3.0

—

Covid-19 confirmed case

4.11

2.35

2.4

2.7

—

Influenza and pneumonia

2.43

2.31

2.7

2.2

—

Benzodiazepine use

2.49

2.30

2.3

2.5

—

Ulcerative colitis

5.56

2.21

2.4

2.9

—

Dysphagia

5.56

2.21

1.6

2.7

—

Dorsalgia

2.41

2.18

2.2

2.7

—

Asthma-related pneumonia

4.27

2.14

2.8

2.4

—

Asthma, hospital admissions 3, pneumonia

4.27

2.14

2.8

2.4

—

Asthma-related pneumonia or sepsis

4.27

2.14

2.8

2.4

—

Umbilical hernia

5.00

2.07

2.6

—

Other acute lower respiratory infections

3.17

2.06

2.3

2.8

—

Acute bronchitis

3.92

2.00

2.3

2.9

—

Other bacterial diseases, including avohilmo

2.39

1.95

2.9

2.4

—

Disturbances of skin sensation

4.55

1.94

1.8

2.6

—

Diseases of liver

3.75

1.93

2.7

—

Disorders of sclera, cornea, iris and ciliary body

2.96

1.93

2.0

2.7

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3.75

1.93

1.5

2.8

—

Presence of other functional implants

3.42

1.90

1.7

2.0

—

Acute tubulo-interstitial nephritis

2.71

1.88

3.0

2.4

—

Bacterial Sepsis

3.54

1.79

2.7

2.6

—

Noninfective enteritis and colitis

3.04

1.79

2.3

2.6

—

Symptoms and signs involving the urinary system

2.61

1.77

2.7

2.5

—

Pneumonia, organism unspecified

2.43

1.77

2.7

2.3

—

All kidney diseases

2.23

1.75

2.9

2.3

—

Other arthritis (FG)

3.33

1.74

1.7

2.6

—

Hernia of abdominal wall

3.33

1.74

2.5

2.6

—

Bacterial infection, other or unspecified

3.37

1.72

2.7

2.3

—

Other viral diseases

3.83

1.71

1.8

2.5

—

Provisional assignment of new diseases of uncertain etiology

2.64

1.70

2.5

2.6

—

Codes for special purposes

2.64

1.70

2.5

2.6

—

Cystitis

2.42

1.70

1.8

2.6

—

Unspecified fall

2.86

1.68

2.0

2.8

—

Autoimmune diseases related-to ILD

2.29

1.65

2.1

2.6

—

Other specified/unspecified arthritis

3.57

1.61

1.6

2.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

3.13

1.61

3.0

2.6

—

Implicit viral Sepsis, including avohilmo

3.56

1.61

3.2

2.4

—

Examination and observation for other reasons

0.00

1.60

0.0

2.4

—

Asthma-related infections

2.52

1.60

2.4

2.5

—

Asthma, hospital admission 2, infections

2.52

1.60

2.4

2.5

—

Abnormalities of heart beat

3.46

1.56

2.4

2.8

—

Codeine

2.24

1.55

2.1

2.3

—

Other disorders of urethra and urinary system

2.61

1.53

1.9

2.6

—

Keratitis

3.33

1.52

1.8

2.5

—

Obesity due to excess calories

2.59

1.51

2.0

2.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.59

1.51

2.3

2.7

—

Ischemic heart diseases

2.55

1.51

1.8

2.6

—

Acute upper respiratory infections

2.18

1.51

2.6

2.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.86

1.50

2.5

2.7

—

Diseases of the digestive system

2.84

1.49

2.3

2.8

—

2.50

1.49

3.2

2.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.50

1.49

3.2

2.2

—

Bacterial infection, other or unspecified, including avohilmo

2.89

1.48

2.7

2.5

—

Sleep apnoea

2.24

1.48

2.2

2.6

—

Malignant neoplasm of skin

3.38

1.46

1.8

3.0

—

STROKE

2.88

1.44

2.8

2.5

—

Sleep apnoea, including avohilmo

2.22

1.44

2.5

2.6

—

Venous thromboembolism

2.75

1.44

1.7

2.6

—

Urticaria

3.12

1.43

2.6

2.3

—

All pneumoniae

2.11

1.43

3.1

2.2

—

Angina pectoris

3.32

1.43

2.2

2.5

—

Meniscus derangement

2.84

1.42

3.2

2.1

—

Inflammatory bowel disease treatment related agents

1.99

1.41

1.9

2.6

—

Glucosamine medication

3.07

1.37

1.8

2.4

—

Asthma (only as main-diagnosis)

2.63

1.36

2.6

2.4

—

In situ neoplasms

2.94

1.36

1.6

2.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.08

1.35

2.0

2.6

—

DVT of lower extremities and pulmonary embolism

2.93

1.35

1.6

2.5

—

Codeine or tramadol medication

2.02

1.35

2.0

2.6

—

Malignant neoplasm of skin, including Hilmo

3.04

1.33

1.8

3.1

—

Urinary track infection

2.50

1.32

2.0

2.5

—

Polyarthropathies

2.45

1.31

2.5

—

Neurological diseases, wide definition

3.14

1.30

3.4

2.1

—

Coronary atherosclerosis

2.87

1.24

2.0

2.5

—

Headache

2.44

1.23

1.3

2.3

—

Other viral diseases, including avohilmo

2.38

1.22

2.0

2.3

—

Urticaria and erythema

2.63

1.21

2.6

2.5

—

All chronic kidney diseases

2.66

1.19

2.6

2.9

—

Oral corticosteroids

1.95

1.18

1.8

2.6

—

Visual disturbances and blindness

2.31

1.18

2.2

2.5

—

Disorders of gallbladder, biliary tract and pancreas

2.07

1.15

1.8

2.7

—

Care involving use of rehabilitation procedures

0.00

1.15

0.0

2.6

—

Asthma (only as main-diagnosis), excluding more controls

2.42

1.14

2.4

2.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.46

1.13

3.2

2.6

—

Concussion

2.36

1.13

2.1

2.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.29

1.11

3.0

2.3

—

Pneumonias (Asthma/COPD co-morbidities)

1.94

1.10

3.0

2.3

—

Injuries to the head

1.84

1.10

1.8

2.6

—

Injuries to the knee and lower leg

1.80

1.10

2.4

—

Persons encountering health services in other circumstances, wide

1.86

1.09

2.0

2.6

—

Ischaemic heart disease, wide definition

2.27

1.09

2.6

2.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.93

1.08

2.1

2.5

—

Asthma, excluding more controls

2.25

1.07

2.4

2.3

—

Fall on same level involving ice and snow

2.12

1.05

3.4

2.3

—

Other diseases of urinary system

2.00

1.05

1.8

2.8

—

Abdominal and pelvic pain

2.01

1.03

2.8

2.5

—

Mental and behavioural disorders due to alcohol

2.27

1.02

2.6

2.7

—

Asthma

2.12

1.02

2.4

—

Injuries to the wrist and hand

1.81

1.00

2.7

2.3

—

COPD differential diagnosis

2.06

0.99

2.7

2.4

—

ILD differential diagnosis

2.06

0.99

2.7

2.4

—

Excluding asthma or asthma-COPD overlap

2.06

0.99

2.7

2.4

—

Other pulmonary diagnosis

2.06

0.99

2.7

2.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

2.29

0.94

1.2

2.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.14

0.91

3.2

2.3

—

Opioids

1.83

0.91

2.1

2.3

—

Excessive earwax

2.09

0.89

2.5

—

First line medication for Crohn's disease

1.74

0.87

2.5

—

Intracranial injury

2.00

0.86

2.0

2.9

—

Diseases of the respiratory system

2.00

0.84

2.8

2.3

—

Injuries to the shoulder and upper arm

1.76

0.83

2.5

—

Mental and behavioural disorders due to psychoactive substance use

1.89

0.82

2.7

—

Constipation

1.75

0.82

2.5

2.3

—

Special screening examination for infectious and parasitic diseases

0.00

0.81

0.0

2.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.77

0.81

2.8

2.4

—

Sleep disorders (combined)

1.74

0.80

2.4

—

Certain infectious and parasitic diseases, including avohilmo

2.28

0.78

3.2

2.3

—

Hernia

1.76

0.77

2.4

—

Any mental disorder

1.72

0.77

3.3

2.5

—

Intracranial trauma

1.89

0.75

2.1

2.4

—

Tonsillectomy and adenotomy

1.87

0.74

2.3

2.5

—

Asthma, hospital admissions , main diagnosis only

1.66

0.74

2.7

2.4

—

Mood disorders, excluding more controls

1.65

0.74

1.9

2.5

—

Spondylopathies

1.80

0.72

1.6

2.5

—

Visual disturbances

2.00

0.72

2.0

2.6

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.71

0.72

2.6

2.4

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.69

0.72

2.2

2.5

—

Other functional intestinal disorders

1.97

0.72

2.6

2.7

—

Chronic periodontitis, complicated

1.95

0.71

2.6

2.3

—

Any gastric operation

1.76

0.71

3.3

2.2

—

GASTRO-related operations

1.76

0.71

3.3

2.3

—

Substance abuse, excluding more controls

1.90

0.69

2.8

2.5

—

Complications of medical and surgical care

1.70

0.69

3.0

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1.69

0.69

1.6

2.7

—

Asthma (diagnoses ohter than nonallergic)

1.55

0.69

2.7

2.4

—

Obesity

1.69

0.69

2.0

2.5

—

Obesity and other hyperalimentation

1.69

0.69

2.0

2.5

—

Shoulder lesions

1.68

0.68

2.7

2.3

—

Transport accidents

1.81

0.66

1.6

2.5

—

Gestational diabetes (for exclusion)

1.81

0.66

2.2

2.8

—

Other nutritional deficiencies

1.60

0.65

2.0

2.5

—

Low back pain

1.69

0.63

2.5

2.7

—

Substance abuse

1.72

0.63

2.8

2.7

—

Depression

1.63

0.63

2.0

2.6

—

1.72

0.63

2.6

2.7

—

Pain in throat and chest

1.63

0.62

2.8

2.6

—

Osteopathies and chondropathies

1.69

0.62

3.0

2.6

—

Symptoms and signs involving the digestive system and abdomen

1.60

0.62

2.5

—

1.67

0.61

2.6

2.7

—

Asthma (mode)

1.85

0.61

2.7

2.4

—

Degeneration of macula and posterior pole

0.00

0.61

0.0

2.1

—

Asthma, including avohilmo

1.54

0.59

2.6

2.3

—

Disorders of skin appendages

1.70

0.57

1.5

2.4

—

Fall on same level

1.52

0.57

2.1

2.5

—

Dermatitis

1.68

0.57

1.8

2.7

—

Necrosis of pulp, including avohilmo

1.60

0.55

2.2

2.4

—

Neurotic, stress-related and somatoform disorders

1.48

0.54

2.6

2.4

—

Depression or dysthymia

1.56

0.53

3.0

2.4

—

Dislocation, sprain and strain of joints and ligaments of knee

1.55

0.53

2.5

—

Anxiety disorders

1.43

0.52

2.6

2.4

—

Dermatitis and eczema

1.48

0.48

1.8

2.6

—

Injuries to the elbow and forearm

1.50

0.48

1.6

2.5

—

Diseases of the ear and mastoid process

0.57

0.48

2.2

2.4

—

Diseases of the skin and subcutaneous tissue

1.52

0.47

1.8

2.7

—

Complications of procedures, not elsewhere classified

1.44

0.46

3.0

2.4

—

Metabolic disorders

1.50

0.44

1.6

2.7

—

Chronic periodontitis, including avohilmo

1.46

0.43

2.6

2.5

—

Periodontitis

1.46

0.43

2.6

2.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.48

0.43

2.0

2.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.61

0.43

2.2

2.5

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.61

0.43

2.0

2.2

—

Pain in limb

1.41

0.42

2.9

2.3

—

Other and unspecified dermatitis

1.56

0.42

2.0

2.6

—

Sulfonylureas

0.00

0.42

0.0

2.5

—

Perineal laceration during delivery

0.00

0.42

0.0

2.9

—

Implicit Sepsis

1.53

0.42

3.2

2.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.41

0.0

2.4

—

Percutaneous Coronary Intervention

1.52

0.41

1.8

2.7

—

Bacterial pneumonia, not elsewhere classified

0.00

0.41

0.0

2.3

—

Coronary revascularization (ANGIO or CABG)

1.52

0.41

1.8

2.7

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.41

0.0

2.5

—

Schizophrenia or delusion, excluding more controls

0.00

0.41

0.0

2.7

—

Candidiasis, including avohilmo

0.00

0.41

0.0

2.5

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.41

0.0

2.5

—

Symptoms and signs involving speech and voice

0.00

0.41

0.0

2.1

—

Retinal detachments and breaks

0.00

0.41

0.0

2.2

—

Rheumatoid arthritis, including avohilmo

0.00

0.41

0.0

2.3

—

Other and unspecified iron deficiency

0.00

0.41

0.0

2.6

—

Bacterial pneumoniae

0.00

0.41

0.0

2.5

—

Kela-code for severe mental illness

0.00

0.40

0.0

2.5

—

Leiomyoma of uterus

1.48

0.40

2.4

2.1

—

Other dorsopathies, not elsewhere classified

1.42

0.40

1.8

2.7

—

Other soft tissue disorders, not elsewhere classified

1.42

0.40

2.7

2.3

—

Episodal and paroxysmal disorders

1.45

0.40

2.7

2.4

—

Dorsopathies

1.38

0.39

1.7

2.7

—

Bacterial pneumonia (organism specified)

0.00

0.39

0.0

2.4

—

Other arrhythmias

1.44

0.39

1.2

2.5

—

Temporomandibular joint disorders, including avohilmo

1.42

0.39

1.6

2.4

—

Mood [affective] disorders

1.37

0.39

1.9

2.6

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.39

0.0

2.5

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.39

0.0

2.5

—

Mood disorders

1.37

0.39

1.9

2.6

—

Tramadol

1.50

0.37

3.0

2.3

—

Disorders of lipoprotein metabolism and other lipidaemias

1.46

0.36

1.8

2.7

—

Major coronary heart disease event

1.43

0.36

1.7

2.7

—

Excessive attrition of teeth

1.45

0.35

2.2

2.5

—

Hard cardiovascular diseases

1.36

0.34

1.5

2.6

—

Cholelithiasis, broad definition with cholecystitis

1.33

0.34

2.2

2.7

—

Anxiety disorders, excluding more controls

1.40

0.32

2.7

2.5

—

Injuries to the ankle and foot

1.36

0.31

2.7

2.4

—

Psychiatric diseases

1.30

0.31

2.9

2.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.30

0.31

2.6

—

Lower back pain or/and sciatica

1.35

0.30

2.6

2.4

—

Dyspnoea

1.26

0.30

2.0

2.6

—

Complications of surgical and medical care, not elsewhere classified

1.30

0.28

2.9

2.4

—

Conjunctivitis (acute, non atopic), including avohilmo

0.67

0.27

2.2

2.4

—

Caries of enamel

0.67

0.26

3.8

2.3

—

Implicit Sepsis, including avohilmo

1.32

0.23

3.2

2.4

—

Gastro-oesophageal reflux disease

1.32

0.23

2.0

2.3

—

Type 2 diabetes, wide definition

1.26

0.23

1.6

2.3

—

Anxiety (asthma-related co-morbidities)

1.27

0.22

3.0

2.4

—

Cardiovascular diseases (excluding rheumatic etc)

1.24

0.22

2.4

2.6

—

Bleeding

1.25

0.22

3.0

2.5

—

Caries of dentine, including avohilmo

1.22

0.22

2.8

2.4

—

Alzheimer disease

0.00

0.22

0.0

2.4

—

Hypertensive heart and/or renal disease

0.00

0.22

0.0

2.0

—

Hypertensive Heart Disease

0.00

0.22

0.0

2.0

—

Outcome of delivery

0.00

0.21

0.0

2.3

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

2.6

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.19

0.21

3.2

2.4

—

Fracture of femur

0.00

0.21

0.0

2.0

—

0.00

0.21

0.0

2.1

—

Abnormal serum enzyme levels

0.00

0.21

0.0

2.9

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.21

0.0

1.7

—

Tinnitus

0.00

0.21

0.0

2.2

—

Benign neoplasm: Colon, unspecified

0.00

0.21

0.0

2.2

—

Fibroblastic disorders

0.00

0.21

0.0

2.4

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.21

0.0

1.7

—

Speech therapy

0.00

0.21

0.0

1.7

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.21

0.0

1.7

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.7

—

Cutaneous abscess, furuncle and carbuncle

0.00

0.21

0.0

2.8

—

Primary open-angle glaucoma, strict

0.00

0.21

0.0

2.2

—

Non-invasive ventilation

0.00

0.21

0.0

2.7

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

2.3

—

Artificial joint operation, meniscal resection

1.28

0.21

3.3

2.2

—

Mycoses

0.00

0.21

0.0

2.4

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

2.5

—

Dysplasia of cervi uteri

0.00

0.20

0.0

2.4

—

Non-ischemic cardiomyopathy

0.00

0.20

0.0

2.5

—

General examination and investigation of persons without complaint and reported diagnosis

1.25

0.20

2.2

2.4

—

Cardiovascular diseases

1.22

0.20

2.2

2.5

—

Primary coxarthrosis, bilateral

0.00

0.20

0.0

2.4

—

Schizophrenia or delusion

0.00

0.20

0.0

2.6

—

Diseases of the eye and adnexa

1.20

0.20

2.7

2.5

—

Rheumatoid arthritis

0.00

0.20

0.0

2.0

—

Any event in cancer register

1.17

0.19

1.7

2.8

—

Dentofacial anomalies [including malocclusion]

1.17

0.19

2.0

2.4

—

Type 2 diabetes, definitions combined, including avohilmo

1.23

0.18

1.9

2.6

—

Abnormalities of breathing

1.21

0.18

2.0

2.5

—

Use of hypnotics and sedatives

1.18

0.18

2.3

2.7

—

Symptoms and signs involving the circulatory and respiratory systems

1.21

0.17

2.4

2.5

—

Falls/tendency to fall

1.21

0.17

2.6

2.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.76

0.17

2.0

2.5

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.75

0.17

3.0

2.3

—

Nerve, nerve root and plexus disorders

1.20

0.17

3.9

2.2

—

Diseases of oesophagus, stomach and duodenum

1.18

0.17

2.9

2.4

—

Asthma/COPD (KELA code 203)

1.19

0.17

1.6

2.4

—

Disorders of the thyroid gland

1.18

0.17

1.9

2.5

—

External causes of morbidity and mortality

1.19

0.10

2.2

2.6

—

Chronic lower respiratory diseases

1.17

0.10

2.3

2.4

—

Solid cancers

1.17

0.10

2.2

2.6

—

Emergency coronary revascularization (for ACS)

1.16

0.10

1.8

2.7

—

Gonarthrosis,primary

1.16

0.10

3.2

2.0

—

Cholelithiasis

1.14

0.10

2.0

2.7

—

All anxiety disorders

1.11

0.10

3.0

2.3

—

Atopic dermatitis

1.11

0.10

1.8

2.4

—

Accidents

1.04

0.09

2.0

2.6

—

Hypothyroidism, strict autoimmune

1.12

0.09

1.8

2.5

—

Disorders of eyelid, lacrimal system and orbit

1.13

0.09

2.7

2.5

—

Triptan medication for migraine, single purchase ok

1.07

0.09

2.5

2.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.07

0.09

2.5

2.3

—

Exposure to other specified factors

1.07

0.08

3.7

2.3

—

Chronic diseases of tonsils and adenoids

1.05

0.08

3.5

2.3

—

Other heart diseases, wide

1.04

0.08

2.0

2.7

—

Other (not insulin) diabetes medications

0.81

0.08

1.6

2.5

—

Type 2 diabetes

0.80

0.08

1.8

2.6

—

Diabetes, insulin treatment (Kela reimbursement)

0.80

0.08

1.8

2.6

—

Sleep disorders

0.76

0.08

2.4

2.3

—

Other antidepressants

1.08

0.08

2.4

2.6

—

Diabetes, varying definitions

1.04

0.08

2.3

2.5

—

Diabetes mellitus

1.04

0.08

2.3

2.5

—

Used for control exclusion in common control thyroid runs

0.82

0.08

2.3

2.4

—

Diseases of pulp and periapical tissues, including avohilmo

0.80

0.08

2.3

2.5

—

Diabetes medication

0.81

0.08

2.0

2.5

—

Chronic apical periodontitis

1.07

0.07

2.9

2.5

—

Other disorders of patella

0.00

0.0

1.8

—

Otitis media, unspecified

0.00

0.0

2.4

—

Coronary artery bypass grafting

0.00

0.0

2.8

—

Eating disorder

0.00

0.0

3.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

2.2

—

Medical observation and evaluation for suspected diseases and conditions

1.02

0.00

2.6

2.4

—

Voice disturbances

0.00

0.0

1.6

—

Impacted maxillary molar

0.00

0.0

3.1

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.0

2.8

—

Other diseases of upper respiratory tract

0.96

0.00

2.6

2.4

—

Alzheimer’s disease (Late onset)

0.00

0.0

2.3

—

Superficial injury of hip and thigh

0.00

0.0

1.6

—

Intermittent heterotropia

0.00

0.0

2.8

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.6

—

Foreign body on external eye

0.00

0.0

2.9

—

Congenital malformations of heart and great arteries

0.00

0.0

3.2

—

Other respiratory disorders and diseases

0.00

0.0

1.6

—

Conjunctivitis

1.01

0.00

3.2

2.3

—

Other inflammation of eyelid

0.00

0.0

2.7

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.01

0.00

2.8

2.4

—

Other eating disorders

0.00

0.0

3.5

—

Neurological diseases

0.97

0.00

3.0

2.4

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.93

0.00

1.8

2.6

—

Lateral epicondylitis

0.00

0.0

1.6

—

Other diseases of the respiratory system

0.00

0.0

1.6

—

Scoliosis

0.00

0.0

3.2

—

Unspecified/other endometriosis

0.00

0.0

4.2

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.0

1.3

—

Congenital malformations of the circulatory system

0.00

0.0

2.8

—

Other problems related to primary support group, including family circumstances

0.00

0.0

2.6

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.5

—

Other disorders starting during childhood or adolescence

0.00

-0.00

0.0

2.8

—

Type 2 diabetes, strict (exclude DM1)

1.03

-0.00

1.8

2.6

—

Selective serotonin reuptake inhibitors

0.94

-0.00

2.7

2.6

—

Other superficial mycoses, including avohilmo

0.00

-0.00

0.0

3.2

—

Inflammatory diseases of female pelvic organs

0.95

-0.00

1.8

2.3

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

2.0

—

Acute appendicitis, with complications

0.00

-0.00

0.0

1.8

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

2.7

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

2.2

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.5

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

2.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

-0.00

0.0

2.6

—

Benign neoplasm: Rectum, anus and anal canal

0.00

-0.00

0.0

1.7

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

3.2

—

Seronegative rheumatoid arthritis

0.00

-0.00

0.0

1.2

—

Other specified and unspecified personality disorders

0.00

-0.00

0.0

3.2

—

Schizophrenia

0.00

-0.00

0.0

2.2

—

Eating disorders

0.00

-0.00

0.0

2.9

—

Other disorders of ear

0.92

-0.00

1.8

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

0.96

-0.00

3.2

2.3

—

Gastrointestinal diseases

0.96

-0.00

2.6

2.7

—

Other congenital malformations, including avohilmo

0.00

-0.00

0.0

3.0

—

Use of pramipexole

0.00

-0.00

0.0

1.3

—

Unspecified privation

0.00

-0.00

0.0

2.0

—

Bitten or struck by other mammals

0.00

-0.00

0.0

2.9

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

2.2

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

3.2

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

2.2

—

Candidiasis

0.00

-0.00

0.0

1.8

—

Insomnia

0.93

-0.00

2.3

2.4

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

2.7

—

Cardiac arrest

0.00

-0.00

0.0

2.2

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

-0.00

0.0

1.3

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

3.2

—

Other condition

0.00

-0.00

0.0

3.0

—

0.00

-0.00

0.0

2.2

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

3.2

—

Viral warts

0.00

-0.00

0.0

3.2

—

Speech and linguistic disorders

0.00

-0.00

0.0

2.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

2.6

—

0.00

-0.00

0.0

2.8

—

Type 2 diabetes, definitions combined

1.03

-0.00

1.8

2.6

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

2.2

—

Wet age-related macular degeneration

0.00

-0.00

0.0

2.1

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

3.0

—

Gastric ulcer

0.00

-0.00

0.0

2.0

—

Gastroduodenal ulcer

0.00

-0.00

0.0

2.4

—

Disorders of conjunctiva

0.93

-0.00

3.2

2.3

—

Continuous positive airway pressure

0.00

-0.00

0.0

2.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

0.96

-0.00

1.8

2.3

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

2.4

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

3.1

—

Polycystic ovarian syndrome, consortium definition

0.96

-0.00

2.0

2.3

—

Hypothyroidism, other/unspecified

0.94

-0.00

1.8

2.5

—

Myopia

0.00

-0.00

0.0

3.0

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

3.1

—

Acne

0.00

-0.00

0.0

3.0

—

Macular pucker

0.00

-0.00

0.0

1.5

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.3

—

Hallux rigidus

0.00

-0.00

0.0

1.6

—

Dental pulpitis, including avohilmo

0.87

-0.00

2.3

2.4

—

Nail disorders

0.00

-0.00

0.0

3.2

—

Superficial injury of ankle and foot

0.00

-0.00

0.0

2.8

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.8

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

2.8

—

Gingivitis and periodontal diseases

1.03

-0.00

2.8

2.4

—

Deep bite

0.00

-0.00

0.0

2.8

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.6

—

Contact with other sharp object(s)

0.00

-0.00

0.0

3.2

—

Status post-ami

0.00

-0.00

0.0

2.7

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

2.2

—

malignant neoplasm of male genital organs, including Hilmo

0.00

-0.00

0.0

3.8

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

2.8

—

Assault

0.00

-0.00

0.0

3.2

—

Presence of other devices

0.00

-0.00

0.0

2.0

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

2.2

—

malignant neoplasm of male genital organs

0.00

-0.00

0.0

3.8

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

2.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.95

-0.00

2.6

2.5

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

2.8

—

Endometriosis ASRM stages 3,4

0.00

-0.00

0.0

1.9

—

Endometriosis of ovary

0.00

-0.00

0.0

3.0

—

Persistent mood disorders

0.00

-0.00

0.0

2.6

—

Use of memantine

0.00

-0.00

0.0

2.4

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

3.6

—

Psoriasis vulgaris

0.00

-0.00

0.0

2.0

—

Crossbite

0.00

-0.00

0.0

2.8

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

2.0

—

Desensitization to allergens

0.00

-0.00

0.0

3.2

—

Benign neoplasm: Rectum

0.00

-0.00

0.0

1.6

—

Hypothyroidism, drug reimbursement

0.00

-0.00

0.0

1.8

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.6

—

Congenital malformations of genital organs

0.00

-0.00

0.0

3.2

—

Other specific joint derangements/joint disorders

0.94

-0.00

3.6

2.4

—

Autoimmune diseases excluding thyroid diseases

0.95

-0.00

2.6

2.5

—

Other skin changes

0.00

-0.00

0.0

2.2

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.9

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

3.0

—

Valvular operations

0.00

-0.00

0.0

2.5

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

2.8

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

3.0

—

Antihypertensive medication - note that there are other indications

0.93

-0.00

1.6

2.5

—

Abnormalities of forces of labour

0.00

-0.00

0.0

2.6

—

Autoimmune diseases

0.89

-0.00

1.9

2.5

—

Finngen Rheumatological endpoints

0.97

-0.00

2.2

2.5

—

Other diseases of intestines

0.91

-0.00

2.1

2.5

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

2.7

—

Acne vulgaris

0.00

-0.00

0.0

3.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

-0.00

0.0

2.8

—

Persons encountering health services for specific procedures and health care

0.88

-0.00

2.1

2.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.87

-0.00

1.8

2.5

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

2.6

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

2.4

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

1.3

—

Misadventures to patients during surgical and medical care

0.00

-0.00

0.0

1.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Plasmodium malariae Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS